Clinical Trial Update: Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion [NA]

View source ↗

Summary

A completed clinical trial compares Actifuse ABX to INFUSE for posterolateral instrumented lumbar fusion in patients with degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Actifuse ABX (calcium phosphate bone graft substitute with antibiotics)
• Infuse (recombinant human bone morphogenetic protein-2)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Degenerative Disc Disease | NA | Status: COMPLETED